| NIROGACESTAT HYDROBROMIDE | None | ||
| 50MG, 100MG, 150MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| OGSIVEO is a gamma secretase inhibitor indicated for adult patients with progressing desmoid tumors who require systemic treatment. | |||
|
Yes
| |||
| OGSIVEO | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 | Patent 22 | Patent 23 | Patent 24 | Patent 25 | Patent 26 | Patent 27 | Patent 28 | Patent 29 | Patent 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||||||||||||||||
| ********* ********* *** *** ********* ** ***************** ********* | ********* ********* *** *** ********* ** ***************** ********* | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | *********** ******** ********* *** ************** ************ | *********** ******** ********* *** ************** ************ | *********** ******** ********* *** ************** ************ | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | *********** ******** ********* *** ************** ************ | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | ********** **** ************ | ************ ** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*- ********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | ********** **** ************ | ********** **** ************ | ********** **** ************ | ********** **** ************ | ********** **** ************ | ********** **** ************ | ********** **** ************ | ********** **** ************ | ********* ** ************ | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | ********** **** ************ | ********* ** ************ | ********* ** ************ | ***** ***** ***** ** (*)-*-(((*)-*,*-********-*,*,*,*-********************-*-**)*****)-*-(*-(*-******-*-(**************)******-*-**)-**-********-*-**)*********** *** **** ******* | ********* ********* *** *** ********* ** ***************** ********* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|